Don’t split hairs when it comes to subspecialties

© Jon Carter 

Related Videos
Related Content

Alzheimer’s disease changes may be reflected in the eyes first

March 24th 2023

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

How deep learning may play a role in predicting retinitis pigmentosa visual impairment

March 14th 2023

Managing a changing landscape of IRD pediatric cases

May 10th 2021

Study examines long-term treatment outcomes of intravitreal bevacizumab in myopic macular neovascularization in high myopia

March 4th 2023

Study: Fovea-involving half dose of PDT proves a safe, long-term treatment option for chronic CSC

March 3rd 2023

Alzheimer’s disease changes may be reflected in the eyes first

March 24th 2023

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

How deep learning may play a role in predicting retinitis pigmentosa visual impairment

March 14th 2023

Managing a changing landscape of IRD pediatric cases

May 10th 2021

Study examines long-term treatment outcomes of intravitreal bevacizumab in myopic macular neovascularization in high myopia

March 4th 2023

Study: Fovea-involving half dose of PDT proves a safe, long-term treatment option for chronic CSC

March 3rd 2023

Alzheimer’s disease changes may be reflected in the eyes first

March 24th 2023

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

How deep learning may play a role in predicting retinitis pigmentosa visual impairment

March 14th 2023

Managing a changing landscape of IRD pediatric cases

May 10th 2021

Study examines long-term treatment outcomes of intravitreal bevacizumab in myopic macular neovascularization in high myopia

March 4th 2023

Study: Fovea-involving half dose of PDT proves a safe, long-term treatment option for chronic CSC

March 3rd 2023
© 2023 MJH Life Sciences

All rights reserved.